Company Filing History:
Years Active: 2012
Title: Maria Labandeira-Rey: Innovator in Antibody Research
Introduction
Maria Labandeira-Rey is a prominent inventor based in Irving, TX (US). She has made significant contributions to the field of medical research, particularly in the development of antibodies for treating infections caused by methicillin-resistant Staphylococcus aureus (MRSA). Her work is vital in addressing the challenges posed by antibiotic-resistant bacteria.
Latest Patents
Maria Labandeira-Rey holds a patent for "Antibodies recognizing a highly expressed putative antigen of CA-MRSA and methods of use." This invention provides MSCRAMM® proteins that are putative highly-expressed antigens from community-associated MRSA (CA-MRSA). The patent outlines methods for generating antibodies that can bind to these antigens, which can be useful in treating or preventing MRSA infections. The invention includes the proteins, antibodies capable of binding these proteins, methods of generating said antibodies, nucleic acids coding for the proteins, and pharmaceutical compositions or vaccines that incorporate these elements.
Career Highlights
Maria is affiliated with The Texas A&M University System, where she continues her research and innovation in the field of immunology. Her work has garnered attention for its potential impact on public health and the treatment of bacterial infections.
Collaborations
Some of her notable coworkers include Magnus A. Hook and Gabriela M. Bowden. Their collaborative efforts contribute to advancing research in the field of infectious diseases and antibody development.
Conclusion
Maria Labandeira-Rey is a key figure in the fight against antibiotic-resistant infections, with her innovative research paving the way for new treatments. Her contributions to the field of antibody research are invaluable and highlight the importance of continued innovation in medical science.